1. Examining internet-delivered cognitive behaviour therapy for patients with chronic kidney disease on haemodialysis: A feasibility open trial
- Author
-
Blake F. Dear, Josephine Chow, Ramony Chan, Nick Titov, and Michael Suranyi
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,030232 urology & nephrology ,Anxiety ,03 medical and health sciences ,0302 clinical medicine ,Quality of life (healthcare) ,Renal Dialysis ,Humans ,Medicine ,030212 general & internal medicine ,Renal Insufficiency, Chronic ,Depression (differential diagnoses) ,Dialysis ,Aged ,Internet ,Cognitive Behavioral Therapy ,Depression ,business.industry ,Australia ,Middle Aged ,medicine.disease ,Mental health ,Clinical trial ,Psychiatry and Mental health ,Clinical Psychology ,Treatment Outcome ,Therapy, Computer-Assisted ,Quality of Life ,Cognitive therapy ,Physical therapy ,Feasibility Studies ,Female ,medicine.symptom ,business ,Follow-Up Studies ,Kidney disease - Abstract
Objective Treating depression among patients with chronic kidney disease (CKD) is imperative because of its high prevalence and health-related costs. However, many patients with CKD experience significant barriers to effective face-to-face psychological treatments. Internet-delivered cognitive behaviour therapy (iCBT) may help overcome the treatment barriers. The aim of the present study was to explore the acceptability and preliminary efficacy of iCBT for depression and anxiety among patients with CKD on haemodialysis. Methods A single-group open trial design involving 22 patients on dialysis and an established iCBT treatment for anxiety and depression was employed. The primary outcomes were symptoms of depression, anxiety and general psychological distress. The secondary and tertiary outcomes were disability, quality of life, kidney disease-related loss and kidney disease burden. A generalised estimation equation modelling technique was employed. Results Clinically significant improvements (avg. % of improvement) were observed in the primary outcomes of depression (34%), anxiety (31%) and general distress (26%), which were maintained or further improved to 3-month follow-up. Improvements were also observed for quality of life (12%) and kidney disease-related loss (30%). However, no improvements in disability and kidney disease burden were found. High levels of acceptability were reported and relatively little clinician time (99.45 min; SD = 14.61) was needed to provide the treatment. Conclusion The present results provide encouraging support for the potential of iCBT as an innovative way of increasing access to effective psychological treatment for CKD patients. These results provide much needed support for further research in this area. Trial registration: Australian and New Zealand Clinical Trials Registry: ACTRN12613000103763.
- Published
- 2016
- Full Text
- View/download PDF